Targeted Therapies in Oncology for Elderly Cancer Patients
Author Information
Author(s): Agostara Biagio, Carruba Giuseppe, Usset Antonella
Primary Institution: Clinical Oncology, Department of Oncology, "M. Ascoli" Cancer Hospital Center, ARNAS-Civico, Palermo, Italy
Hypothesis
The management of elderly cancer patients should be revisited in light of recent advances in targeted therapies.
Conclusion
Targeted therapies show promise in improving treatment outcomes for elderly cancer patients while minimizing side effects.
Supporting Evidence
- Targeted therapies can minimize side effects compared to traditional treatments.
- Older cancer patients often have unique treatment challenges due to frailty and comorbidities.
- Clinical trials are needed to better understand the effectiveness of targeted therapies in elderly patients.
Takeaway
This study talks about how new cancer treatments that target specific parts of cancer cells can help older people with cancer feel better and live longer.
Limitations
The study does not specify limitations but highlights the need for more clinical trials focused on elderly patients.
Participant Demographics
The study emphasizes the growing population of cancer patients over 65 years old.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website